Blog Archives
Welcome New Members!
Modular Genetics is a sustainable chemistry company with a patented, automated strain engineering process which enables the modification of various organisms to produce green specialty chemicals via fermentation. Modular is focused on sustainable chemistry and is a leading company in today’s Industrial Biotechnology Revolution. Modular is positioned to take a leading role as the world transitions from a petroleum-based economy to an economy based on renewable raw materials.
RVC USA / Maxwell Biotech is a visionary and strategic investor of early-stage capital that melds the innovation of U.S. start-ups with the resources of Russia. Whether your focus is information technology, life sciences, semi-conductor or alternative energy/clean technology, we have a strong track record of delivering value beyond 
capital that ensures your venture is primed and ready for the next phase of growth.
Celexion LLC is a protein discovery and engineering company based in Cambridge, Massachusetts. We use our proprietary platform to display complex proteins on the surface of eukaryotic cells. This platform combined with state-of-the-art library construction and screening capabilities, allows us to rapidly discover and engineer new proteins for applications in therapeutics, diagnostics, and life science tools.
Top 5 News Stories 2/17-2/24
1. Newly-approved FDA drug dramatically changing lives of CF patients Fox News – 2/17/12
On the surface, Lindsay Shipp’s story may sound sad, but it’s a story of hope with a happy ending. All her life, Shipp has been trying to keep up a positive attitude. She knew the disease from which she suffered – cystic fibrosis – could cut her life short, but she tried to play it off like she was fine. Link
2. FDA to ease critical cancer drug shortage with help from new suppliers CBS News – 2/21/12
The federal government is stepping in to help ease the shortage of two life-saving cancer drugs, Doxil and methotrexate, regulators announced Tuesday. The FDA said it will temporarily allow importation of a replacement drug for Doxil, a drug for ovarian and other cancers that hasn’t been available for new patients for months. Link
3. Mass. gives $21M in life sciences tax breaks Boston Herald Biz Smart – 2/22/12
The Massachusetts Life Sciences Center today announced its board of directors had awarded $21.2 million in tax incentives to 28 life sciences companies that have committed to creating more than 940 new jobs this year. Link
